GARY A LYONS Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for GARY A LYONS.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of GARY A LYONS. GARY A LYONS is in Brickell Biotech, Inc. ($VICL) and Director in VICAL INC ($VICL) and Director in NEUROCRINE BIOSCIENCES INC ($NBIX) and Director in Ardea Biosciences, Inc./DE ($IBPI) and Director in RIGEL PHARMACEUTICALS INC ($RIGL) and Director in CYTORI THERAPEUTICS, INC. ($XMP) and Director in KALOBIOS PHARMACEUTICALS INC ($KBIO) and Director in Novus Therapeutics, Inc. ($TKAI) and Director in Retrophin, Inc. ($RTRX).

Latest Insider Trading Transactions of GARY A LYONS

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, IBPI, VICL, ELDN, KBIO, NBIX, PSTV, RIGL, RTRX

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
May 18 2021	RTRX	Travere Therapeuti ...	LYONS GARY A	Director	Option Exercise	A	18.27	9,000	164,430	9,000
May 18 2021	RTRX	Travere Therapeuti ...	LYONS GARY A	Director	Grant	A	0.00	3,000	0	37,000	34 K to 37 K (+8.82 %)
Jan 27 2021	NBIX	NEUROCRINE BIOSCIE ...	LYONS GARY A	Director	Sell	S	120.00	400	48,000	223,697	224.1 K to 223.7 K (-0.18 %)
Jan 27 2021	NBIX	NEUROCRINE BIOSCIE ...	LYONS GARY A	Director	Sell	S	120.03	1,600	192,047	224,097	225.7 K to 224.1 K (-0.71 %)
Sep 17 2020	VICL	Brickell Biotech, ...	LYONS GARY A	Director	Option Exercise	A	0.80	60,000	48,000	60,000
Sep 17 2020	VICL	Brickell Biotech, ...	LYONS GARY A	Director	Grant	A	0.81	11,934	9,667	24,729	12.8 K to 24.7 K (+93.27 %)
Sep 15 2020	NVUS	Novus Therapeutics ...	LYONS GARY A	Director	Option Exercise	A	500.00	1,167	583,500	1,167
Sep 02 2020	VICL	Brickell Biotech, ...	LYONS GARY A	Director	Option Exercise	M	0.00	692	0	0
Sep 02 2020	VICL	Brickell Biotech, ...	LYONS GARY A	Director	Payment of Exercise	F	0.94	8,631	8,113	12,795	21.4 K to 12.8 K (-40.28 %)
Sep 02 2020	VICL	Brickell Biotech, ...	LYONS GARY A	Director	Payment of Exercise	F	0.94	346	325	21,426	21.8 K to 21.4 K (-1.59 %)
Sep 02 2020	VICL	Brickell Biotech, ...	LYONS GARY A	Director	Buy	M	0.00	692	0	21,772	21.1 K to 21.8 K (+3.28 %)
Aug 04 2020	VICL	Brickell Biotech, ...	LYONS GARY A	Director	Option Exercise	M	0.00	692	0	692
Aug 04 2020	VICL	Brickell Biotech, ...	LYONS GARY A	Director	Payment of Exercise	F	0.92	346	318	21,080	21.4 K to 21.1 K (-1.61 %)
Aug 04 2020	VICL	Brickell Biotech, ...	LYONS GARY A	Director	Buy	M	0.00	692	0	21,426	20.7 K to 21.4 K (+3.34 %)
Jul 02 2020	VICL	Brickell Biotech, ...	LYONS GARY A	Director	Option Exercise	M	0.00	691	0	1,384
Jul 02 2020	VICL	Brickell Biotech, ...	LYONS GARY A	Director	Payment of Exercise	F	1.00	346	346	20,734	21.1 K to 20.7 K (-1.64 %)
Jul 02 2020	VICL	Brickell Biotech, ...	LYONS GARY A	Director	Buy	M	0.00	691	0	21,080	20.4 K to 21.1 K (+3.39 %)
Jun 05 2020	VICL	Brickell Biotech, ...	LYONS GARY A	Director	Option Exercise	A	1.12	4,333	4,853	4,333
Jun 05 2020	VICL	Brickell Biotech, ...	LYONS GARY A	Director	Option Exercise	M	0.00	692	0	692
Jun 05 2020	VICL	Brickell Biotech, ...	LYONS GARY A	Director	Option Exercise	M	0.00	692	0	692
Jun 05 2020	VICL	Brickell Biotech, ...	LYONS GARY A	Director	Option Exercise	M	0.00	691	0	691
Jun 05 2020	VICL	Brickell Biotech, ...	LYONS GARY A	Director	Option Exercise	M	0.00	692	0	692
Jun 05 2020	VICL	Brickell Biotech, ...	LYONS GARY A	Director	Option Exercise	M	0.00	3,491	0	3,491
Jun 05 2020	VICL	Brickell Biotech, ...	LYONS GARY A	Director	Grant	A	0.00	17,261	0	20,389	3.1 K to 20.4 K (+551.82 %)
Jun 05 2020	VICL	Brickell Biotech, ...	LYONS GARY A	Director	Payment of Exercise	F	1.16	346	401	3,128	3.5 K to 3.1 K (-9.96 %)
Jun 05 2020	VICL	Brickell Biotech, ...	LYONS GARY A	Director	Buy	M	0.00	692	0	3,474	2.8 K to 3.5 K (+24.87 %)
Jun 05 2020	VICL	Brickell Biotech, ...	LYONS GARY A	Director	Payment of Exercise	F	1.20	346	415	2,782	3.1 K to 2.8 K (-11.06 %)
Jun 05 2020	VICL	Brickell Biotech, ...	LYONS GARY A	Director	Buy	M	0.00	692	0	3,128	2.4 K to 3.1 K (+28.41 %)
Jun 05 2020	VICL	Brickell Biotech, ...	LYONS GARY A	Director	Payment of Exercise	F	1.19	346	412	2,436	2.8 K to 2.4 K (-12.44 %)
Jun 05 2020	VICL	Brickell Biotech, ...	LYONS GARY A	Director	Buy	M	0.00	691	0	2,782	2.1 K to 2.8 K (+33.05 %)
Jun 05 2020	VICL	Brickell Biotech, ...	LYONS GARY A	Director	Payment of Exercise	F	2.93	346	1,014	2,091	2.4 K to 2.1 K (-14.20 %)
Jun 05 2020	VICL	Brickell Biotech, ...	LYONS GARY A	Director	Buy	M	0.00	692	0	2,437	1.7 K to 2.4 K (+39.66 %)
Jun 05 2020	VICL	Brickell Biotech, ...	LYONS GARY A	Director	Payment of Exercise	F	1.16	1,746	2,025	1,745	3.5 K to 1.7 K (-50.01 %)
Jun 05 2020	VICL	Brickell Biotech, ...	LYONS GARY A	Director	Buy	M	0.00	3,491	0	3,491	0 to 3.5 K
May 21 2020	NBIX	NEUROCRINE BIOSCIE ...	LYONS GARY A	Director	Option Exercise	A	119.93	6,018	721,739	6,018
May 19 2020	RTRX	Retrophin, Inc.	LYONS GARY A	Director	Option Exercise	A	15.43	9,000	138,870	9,000
May 19 2020	RTRX	Retrophin, Inc.	LYONS GARY A	Director	Grant	A	0.00	3,000	0	34,000	31 K to 34 K (+9.68 %)
May 15 2020	RIGL	RIGEL PHARMACEUTIC ...	LYONS GARY A	Director	Option Exercise	A	1.77	55,000	97,075	55,000
May 15 2020	RIGL	RIGEL PHARMACEUTIC ...	LYONS GARY A	Director	Option Exercise	A	1.77	55,000	97,075	55,000
Feb 19 2020	VICL	Brickell Biotech, ...	LYONS GARY A		Option Exercise	A	1.16	8,333	9,666	8,333
Feb 19 2020	VICL	Brickell Biotech, ...	LYONS GARY A		Option Exercise	A	1.16	2,167	2,514	2,167
Nov 13 2019	NBIX	NEUROCRINE BIOSCIE ...	LYONS GARY A	Director	Sell	S	110.00	5,000	550,000	225,697	230.7 K to 225.7 K (-2.17 %)
Nov 05 2019	NBIX	NEUROCRINE BIOSCIE ...	LYONS GARY A	Director	Sell	S	100.22	5,000	501,104	230,697	235.7 K to 230.7 K (-2.12 %)
Jul 31 2019	NBIX	NEUROCRINE BIOSCIE ...	LYONS GARY A	Director	Sell	S	92.07	10,000	920,686	235,697	245.7 K to 235.7 K (-4.07 %)
Jul 15 2019	NVUS	Novus Therapeutics ...	LYONS GARY A	Director	Option Exercise	A	0.88	20,000	17,600	20,000
May 24 2019	RIGL	RIGEL PHARMACEUTIC ...	LYONS GARY A	Director	Option Exercise	A	2.02	55,000	111,100	55,000
May 23 2019	NBIX	NEUROCRINE BIOSCIE ...	LYONS GARY A	Director	Option Exercise	A	79.79	10,000	797,900	10,000
May 10 2019	RTRX	Retrophin, Inc.	LYONS GARY A	Director	Option Exercise	A	17.94	8,000	143,520	8,000
May 10 2019	RTRX	Retrophin, Inc.	LYONS GARY A	Director	Grant	A	0.00	2,000	0	31,000	29 K to 31 K (+6.90 %)
Nov 05 2018	NBIX	NEUROCRINE BIOSCIE ...	LYONS GARY A	Director	Sell	S	114.41	15,000	1,716,213	245,697	260.7 K to 245.7 K (-5.75 %)
Jun 15 2018	NBIX	NEUROCRINE BIOSCIE ...	LYONS GARY A	Director	Sell	S	99.24	15,000	1,488,549	260,697	275.7 K to 260.7 K (-5.44 %)
Jun 14 2018	NVUS	Novus Therapeutics ...	LYONS GARY A	Director	Option Exercise	A	6.18	9,100	56,238	9,100
May 25 2018	NBIX	NEUROCRINE BIOSCIE ...	LYONS GARY A	Director	Option Exercise	A	94.64	12,500	1,183,000	12,500
May 25 2018	NBIX	NEUROCRINE BIOSCIE ...	LYONS GARY A	Director	Option Exercise	A	94.64	12,500	1,183,000	12,500
May 24 2018	VICL	VICAL INC	LYONS GARY A	Director	Option Exercise	A	1.67	6,500	10,855	6,500
May 18 2018	RIGL	RIGEL PHARMACEUTIC ...	LYONS GARY A	Director	Option Exercise	A	3.98	40,000	159,200	40,000
May 11 2018	RTRX	Retrophin, Inc.	LYONS GARY A	Director	Option Exercise	A	26.52	10,000	265,200	10,000
May 11 2018	RTRX	Retrophin, Inc.	LYONS GARY A	Director	Grant	A	0.00	2,500	0	29,000	26.5 K to 29 K (+9.43 %)
Apr 05 2018	NBIX	NEUROCRINE BIOSCIE ...	LYONS GARY A	Director	Option Exercise	M	7.05	15,000	105,750	0
Apr 05 2018	NBIX	NEUROCRINE BIOSCIE ...	LYONS GARY A	Director	Payment of Exercise	F	77.23	1,369	105,728	275,697	277.1 K to 275.7 K (-0.49 %)
Apr 05 2018	NBIX	NEUROCRINE BIOSCIE ...	LYONS GARY A	Director	Buy	M	7.05	15,000	105,750	277,066	262.1 K to 277.1 K (+5.72 %)
Feb 20 2018	NBIX	NEUROCRINE BIOSCIE ...	LYONS GARY A	Director	Sell	S	84.67	5,000	423,341	262,066	267.1 K to 262.1 K (-1.87 %)
Feb 07 2018	NBIX	NEUROCRINE BIOSCIE ...	LYONS GARY A	Director	Sell	S	83.08	5,000	415,380	267,066	272.1 K to 267.1 K (-1.84 %)
Dec 05 2017	NBIX	NEUROCRINE BIOSCIE ...	LYONS GARY A	Director	Sell	S	72.92	10,000	729,182	272,066	282.1 K to 272.1 K (-3.55 %)
Jul 05 2017	TKAI	Novus Therapeutics ...	LYONS GARY A	Director	Option Exercise	A	5.85	18,000	105,300	18,000
Jun 08 2017	NBIX	NEUROCRINE BIOSCIE ...	LYONS GARY A	Director	Option Exercise	A	53.64	15,000	804,600	15,000
May 30 2017	VICL	VICAL INC	LYONS GARY A	Director	Option Exercise	A	2.36	6,500	15,340	6,500
May 18 2017	RTRX	Retrophin, Inc.	LYONS GARY A	Director	Option Exercise	A	17.44	10,000	174,400	10,000
May 18 2017	RTRX	Retrophin, Inc.	LYONS GARY A	Director	Grant	A	0.00	2,500	0	26,500	24 K to 26.5 K (+10.42 %)
May 12 2017	RIGL	RIGEL PHARMACEUTIC ...	LYONS GARY A	Director	Option Exercise	A	2.61	40,000	104,400	40,000
Feb 15 2017	NBIX	NEUROCRINE BIOSCIE ...	LYONS GARY A	Director	Option Exercise	M	3.40	15,000	51,000	0
Feb 15 2017	NBIX	NEUROCRINE BIOSCIE ...	LYONS GARY A	Director	Buy	M	3.40	15,000	51,000	282,066	267.1 K to 282.1 K (+5.62 %)
Jan 27 2017	XMP	CYTORI THERAPEUTIC ...	LYONS GARY A	Director	Option Exercise	A	1.56	25,000	39,000	25,000
Dec 07 2016	VICL	VICAL INC	LYONS GARY A	Director	Sell	S	2.30	7,078	16,248	7,828	14.9 K to 7.8 K (-47.48 %)
Jun 16 2016	XMP	CYTORI THERAPEUTIC ...	LYONS GARY A	Director	Option Exercise	X	3.06	950	2,907	950
Jun 16 2016	XMP	CYTORI THERAPEUTIC ...	LYONS GARY A	Director	Option Exercise	X	2.55	1,900	4,845	0
Jun 16 2016	XMP	CYTORI THERAPEUTIC ...	LYONS GARY A	Director	Buy	X	0.00	1,900	0	4,358	2.5 K to 4.4 K (+77.30 %)
Jun 06 2016	VICL	VICAL INC	LYONS GARY A	Director	Buy	P	4.39	7,078	31,089	14,906	7.8 K to 14.9 K (+90.42 %)
May 24 2016	NBIX	NEUROCRINE BIOSCIE ...	LYONS GARY A	Director	Option Exercise	A	47.89	15,000	718,350	15,000
May 24 2016	VICL	VICAL INC	LYONS GARY A	Director	Option Exercise	A	0.36	65,000	23,465	65,000
May 19 2016	RTRX	Retrophin, Inc.	LYONS GARY A	Director	Option Exercise	A	16.33	8,000	130,640	8,000
May 19 2016	RTRX	Retrophin, Inc.	LYONS GARY A	Director	Grant	A	0.00	2,000	0	24,000	22 K to 24 K (+9.09 %)
May 12 2016	RIGL	RIGEL PHARMACEUTIC ...	LYONS GARY A	Director	Option Exercise	A	2.40	40,000	96,000	40,000
May 10 2016	NBIX	NEUROCRINE BIOSCIE ...	LYONS GARY A	Director	Option Exercise	M	3.07	15,000	46,050	0
May 10 2016	NBIX	NEUROCRINE BIOSCIE ...	LYONS GARY A	Director	Buy	M	3.07	15,000	46,050	267,066	252.1 K to 267.1 K (+5.95 %)
Jan 04 2016	XMP	CYTORI THERAPEUTIC ...	LYONS GARY A	Director	Option Exercise	A	0.00	53,820	0	99,820
Sep 21 2015	NBIX	NEUROCRINE BIOSCIE ...	LYONS GARY A	Director	Sell	S	54.66	5,000	273,300	252,066	257.1 K to 252.1 K (-1.95 %)
Sep 21 2015	NBIX	NEUROCRINE BIOSCIE ...	LYONS GARY A	Director	Sell	S	55.00	10,000	550,000	257,066	267.1 K to 257.1 K (-3.74 %)
Jul 14 2015	KBIO	KALOBIOS PHARMACEU ...	LYONS GARY A	Director	Option Exercise	A	3.68	5,000	18,400	5,000
Jun 10 2015	RTRX	Retrophin, Inc.	LYONS GARY A	Director	Option Exercise	A	32.59	8,000	260,720	8,000
Jun 10 2015	RTRX	Retrophin, Inc.	LYONS GARY A	Director	Grant	A	0.00	2,000	0	22,000	20 K to 22 K (+10.00 %)
Jun 01 2015	NBIX	NEUROCRINE BIOSCIE ...	LYONS GARY A	Director	Option Exercise	A	42.76	25,000	1,069,000	25,000
May 26 2015	VICL	VICAL INC	LYONS GARY A	Director	Option Exercise	A	0.89	50,000	44,500	50,000
May 26 2015	VICL	VICAL INC	LYONS GARY A	Director	Grant	A	0.01	7,500	75	78,281	70.8 K to 78.3 K (+10.60 %)
May 18 2015	XMP	CYTORI THERAPEUTIC ...	LYONS GARY A	Director	Grant	A	0.00	12,440	0	12,440	0 to 12.4 K
May 14 2015	RIGL	RIGEL PHARMACEUTIC ...	LYONS GARY A	Director	Option Exercise	A	3.96	40,000	158,400	40,000
Mar 24 2015	NBIX	NEUROCRINE BIOSCIE ...	LYONS GARY A	Director	Sell	S	41.53	30,000	1,245,900	267,066	297.1 K to 267.1 K (-10.10 %)
Apr 15 2005	IBPI	Ardea Biosciences, ...	LYONS GARY A	Director	Option Exercise	A	4.08	17,500	71,400	62,499
Jun 15 2004	IBPI	Ardea Biosciences, ...	LYONS GARY A	Director	Option Exercise	A	13.93	2,500	34,825	44,999
Jun 15 2004	IBPI	Ardea Biosciences, ...	LYONS GARY A	Director	Option Exercise	A	13.93	15,000	208,950	42,499
Feb 04 2004	IBPI	Ardea Biosciences, ...	LYONS GARY A	Director	Option Exercise	A	16.49	10,000	164,900	27,499
Feb 04 2004	IBPI	Ardea Biosciences, ...	LYONS GARY A	Director	Option Exercise	A	16.49	10,000	164,900	17,499

Page: 1